NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from LP Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+13 more ↓
67%
Finnrick rating
#380 of 419 Retatrutide vendors
28 of 43 classifiable tests passed
customers 4.3★ (113)
methodology · Purity focus
Finnrick analysis · Retatrutide

Repeated identity failures—not purity misses—hold LP Peptide's retatrutide profile down, though results turned into a recent pass streak. Check whether that rebound outweighs earlier failed IDs and fill swings such as +34% and +30%.

methodology →
vendor intelligence report
Vendor Intelligence Report: LP Peptide

Corporate records and storefront policies leave the seller, merchant and quality sign-off chain unattributed. Shared catalog assets, Yuan PDF links, crypto checkout and lookalike domains map a wider network than LP’s factory-direct pitch.

34 pages15 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
79%
16
2
Ipamorelin
$0.66
71%
2
3
Retatrutideselected
$0.74
67%
44
4
Tirzepatide
$0.33
67%
15
5
BPC-157
$0.69
51%
6
6
Tesamorelin
$1.69
44%
15
7
MOTS-c
$0.45
29%
3
8
CJC-1295
$1.05
26%
2
9
NAD+
$0.01
21%
4
10
Cagrilintide
$2.00
-
0
11
CJC-IPA
-
-
0
12
Glutathione
$0.00
-
0
13
IGF-1 LR3
$42.00
-
0
14
KLOW
$0.26
-
0
16
PT-141
$1.00
-
0
17
Selank
$0.70
-
0
18
Semax
$0.70
-
0
20
TB-500
$1.35
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%6 Jun 2026: 80%22 Jun 2026: 76%22 Jun 2026: 72%13 Jul 2026: 68%13 Jul 2026: 64%13 Jul 2026: 60%14 Jul 2026: 56%17 Jul 2026: 52%20 Jul 2026: 54%3 Aug 2026: 55%3 Aug 2026: 57%6 Aug 2026: 54%9 Aug 2026: 55%9 Aug 2026: 57%13 Aug 2026: 59%20 Aug 2026: 56%9 Sep 2026: 53%9 Sep 2026: 55%9 Sep 2026: 53%16 Sep 2026: 54%18 Sep 2026: 56%24 Sep 2026: 53%24 Sep 2026: 51%24 Sep 2026: 53%25 Sep 2026: 54%25 Sep 2026: 56%30 Sep 2026: 57%30 Sep 2026: 58%30 Sep 2026: 59%8 Oct 2026: 57%9 Oct 2026: 56%13 Oct 2026: 57%20 Oct 2026: 58%2 Nov 2026: 59%5 Nov 2026: 60%5 Nov 2026: 61%9 Nov 2026: 62%9 Nov 2026: 63%9 Nov 2026: 64%9 Nov 2026: 65%9 Nov 2026: 66%10 Nov 2026: 66%10 Nov 2026: 67%15 Nov 2026: current 67%80%55%67%Jun 26Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from LP Peptide? Mail in a sample (US only) and let us test it.

Test my supply
LP Peptide Retatrutide test history
COA-backed lab tests
1-10 of 44

About LP Peptide test results from Finnrick

LP Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 107 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LP Peptide peptides in this dataset are BPC-157 (6 tests), CJC-1295 (2 tests) and GHK-Cu (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 107 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from LP Peptide? Mail in a sample (US only) and let us test it.

Test my supply